Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
暂无分享,去创建一个
Arie Perry | Mark A Watson | Michael R Chicoine | Guido Reifenberger | David H Gutmann | G. Reifenberger | M. Watson | D. Gutmann | M. Chicoine | A. Perry | E. Lusis | Eriks A Lusis | Meghan Lyman | Peter Roerig | P. Roerig | M. Lyman | Eriks A. Lusis
[1] B. Scheithauer,et al. Chromosome 1p and 14q FISH Analysis in Clinicopathologic Subsets of Meningioma: Diagnostic and Prognostic Implications , 2001, Journal of neuropathology and experimental neurology.
[2] J. Troncoso,et al. NDRG2: a novel Alzheimer's disease associated protein , 2004, Neurobiology of Disease.
[3] Arie Perry,et al. “Malignancy” in meningiomas , 1999 .
[4] S. Leung,et al. N‐Myc downstream‐regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation , 2003, International journal of cancer.
[5] M. Wolter,et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] Arie Perry,et al. Molecular pathogenesis of meningiomas , 2004, Journal of Neuro-Oncology.
[7] Hassan M Fathallah-Shaykh,et al. Genomic Expression Discovery Predicts Pathways and Opposing Functions behind Phenotypes* , 2003, Journal of Biological Chemistry.
[8] Kwang Dong Kim,et al. Expression and regulation of NDRG2 (N‐myc downstream regulated gene 2) during the differentiation of dendritic cells , 2003, FEBS letters.
[9] Webster K. Cavenee,et al. Pathology and genetics of tumours of the nervous system. , 2000 .
[10] B. Scheithauer,et al. Loss of Tumor Suppressor in Lung Cancer‐1 (TSLC1) Expression in Meningioma Correlates with Increased Malignancy Grade and Reduced Patient Survival , 2004, Journal of neuropathology and experimental neurology.
[11] Fuchu He,et al. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family , 2004, Molecular and Cellular Biochemistry.
[12] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Gutmann,et al. Identification of a third Protein 4.1 tumor suppressor, Protein 4.1R, in meningioma pathogenesis , 2003, Neurobiology of Disease.
[14] N. Farman,et al. Characterization of Rat NDRG2 (N-Myc Downstream Regulated Gene 2), a Novel Early Mineralocorticoid-specific Induced Gene* , 2002, The Journal of Biological Chemistry.
[15] I. Newsham,et al. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. , 2000, Human molecular genetics.
[16] Arie Perry,et al. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. , 2002, The American journal of pathology.
[17] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[18] D. Gutmann,et al. Loss of neurofibromatosis 1 (NF1) gene expression in NF1‐associated pilocytic astrocytomas , 2000, Neuropathology and applied neurobiology.
[19] H. Kondoh,et al. N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant , 1999, Mechanisms of Development.